Skip to main content
Clinical Trials/IRCT20240629062278N1
IRCT20240629062278N1
Recruiting
Phase 3

The Effects of probiotic supplementation on related side effects after chemotherapy and laboratory symptoms in metastatic gastrointestinal cancer patients:A randomized control trial

Shahid Beheshti University of Medical Sciences0 sites160 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
GI Metastatic Cancer.
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
160
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 65\-18 years old with metastatic GI cancer undergoing chemotherapy
  • No lactose intolerance
  • Did not have any symptoms of diarrhea, constipation, nausea, vomiting, or mucositis before receiving chemotherapy,
  • Functional status 0 or 1 according to ECOG (Eastern Cooperative Oncology Group)

Exclusion Criteria

  • Reluctance of the patient to participate in the study
  • Description of underlying diseases including IBD
  • \\History of Colectomy
  • Taking any antibiotic or other drugs

Outcomes

Primary Outcomes

Not specified

Similar Trials